Please login to the form below

Not currently logged in

Krystal Biotech

This page shows the latest Krystal Biotech news and features for those working in and with pharma, biotech and healthcare.

Abeona Therapeutics’ rare disease phase 3 trial halted due to FDA concerns

Abeona Therapeutics’ rare disease phase 3 trial halted due to FDA concerns

Following the news, the biotech’s shared dropped more than 20%, as investors became spooked by potential unfavourable results from the pivotal study. ... Krystal Biotech is also  developing a candidate for RDEB – KB103 – and reported positive

Latest news

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...